ASAS consensus definition of early axial spondyloarthritis
暂无分享,去创建一个
R. Landewé | L. Gensler | S. Ramiro | H. Marzo-Ortega | F. E. Van den Bosch | D. Poddubnyy | U. Weber | A. V. van Tubergen | F. V. van Gaalen | R. Sengupta | A. Moltó | C. López-Medina | V. Navarro-Compán | D. van der Heijde | D. Benavent | D. Capelusnik | R. Perez-Alamino | M. Rudwaleit | X. Baraliakos | M. G. van de Sande
[1] R. Landewé,et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update , 2022, Annals of the Rheumatic Diseases.
[2] R. Landewé,et al. Treating spondyloarthritis early: does it matter? Results from a systematic literature review. , 2022, Rheumatology.
[3] R. Landewé,et al. How is early spondyloarthritis defined in the literature? Results from a systematic review. , 2022, Seminars in arthritis and rheumatism.
[4] D. M. van der Heijde,et al. Axial spondyloarthritis , 2021, Annals of the Rheumatic Diseases.
[5] J. Sieper,et al. Twenty years of clinical trials in axial spondyloarthritis: what can we learn for the future? , 2021, Current opinion in rheumatology.
[6] C. Bundy,et al. Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis , 2021, Rheumatology.
[7] M. Østergaard,et al. Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine , 2020, Annals of the Rheumatic Diseases.
[8] D. M. van der Heijde,et al. Two different invitation approaches for consecutive rounds of a Delphi survey led to comparable final outcome. , 2020, Journal of clinical epidemiology.
[9] M. Dougados,et al. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis , 2019, Annals of the rheumatic diseases.
[10] A. Zink,et al. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. , 2019, Rheumatology.
[11] M. Dougados,et al. Measuring spinal mobility in early axial spondyloarthritis: does it matter? , 2019, Rheumatology.
[12] M. Dougados,et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019 , 2019, Annals of the rheumatic diseases.
[13] K. Raza,et al. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives , 2019, RMD Open.
[14] D. M. van der Heijde,et al. Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis , 2018, The Journal of Rheumatology.
[15] A. Bennett,et al. Short-term Repeat Magnetic Resonance Imaging Scans in Suspected Early Axial Spondyloarthritis Are Clinically Relevant Only in HLA-B27–positive Male Subjects , 2017, The Journal of Rheumatology.
[16] M. Dougados,et al. Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study , 2017, Arthritis care & research.
[17] R. Landewé,et al. Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis , 2017, RMD Open.
[18] M. Dougados,et al. 2016 update of the EULAR recommendations for the management of early arthritis , 2016, Annals of the rheumatic diseases.
[19] J. Braun,et al. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort , 2016, Annals of the rheumatic diseases.
[20] E. Naredo,et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice , 2015, Annals of the rheumatic diseases.
[21] V. Mazurov,et al. Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2 , 2013, Annals of the rheumatic diseases.
[22] D. M. van der Heijde,et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort , 2012, Annals of the rheumatic diseases.
[23] Andreas Krause,et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial , 2011, Annals of the rheumatic diseases.
[24] M. Dougados,et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general , 2010, Annals of the rheumatic diseases.
[25] M. Dougados,et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection , 2009, Annals of the rheumatic diseases.
[26] M. Soucek,et al. AXIAL SPONDYLOARTHRITIS , 2023 .